Pfizer enters 2026 with a tempered outlook and a busy integration agenda as it pivots from the COVID era toward oncology, obesity, and other durable categories. According to CNBC, the company guided... Read more »
I was looking across the internet and could not find a simple calculation that will help me understand if I will run out of money over a period of years given a... Read more »
Wells Fargo price-to-tangible book sits at about 1.48 and is trading roughly where it left off before the pandemic. Given that it is now considered more valuable than Citigroup, which doesn’t have... Read more »
I wrote previously how WBA stock is undervalued, but also has potential to take advantage of one hour delivery of not only life saving drugs, but many of its thousands of retail... Read more »
In late 2015, Walgreens announced that it would acquire Rite Aid stores for $17.2 billion, and that was about the time WBA stock peaked. Then on June 29, 2017, antitrust regulators only... Read more »